Liu Weimin, Worobey Michael, Li Yingying, Keele Brandon F, Bibollet-Ruche Frederic, Guo Yuanyuan, Goepfert Paul A, Santiago Mario L, Ndjango Jean-Bosco N, Neel Cecile, Clifford Stephen L, Sanz Crickette, Kamenya Shadrack, Wilson Michael L, Pusey Anne E, Gross-Camp Nicole, Boesch Christophe, Smith Vince, Zamma Koichiro, Huffman Michael A, Mitani John C, Watts David P, Peeters Martine, Shaw George M, Switzer William M, Sharp Paul M, Hahn Beatrice H
Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
PLoS Pathog. 2008 Jul 4;4(7):e1000097. doi: 10.1371/journal.ppat.1000097.
Identifying microbial pathogens with zoonotic potential in wild-living primates can be important to human health, as evidenced by human immunodeficiency viruses types 1 and 2 (HIV-1 and HIV-2) and Ebola virus. Simian foamy viruses (SFVs) are ancient retroviruses that infect Old and New World monkeys and apes. Although not known to cause disease, these viruses are of public health interest because they have the potential to infect humans and thus provide a more general indication of zoonotic exposure risks. Surprisingly, no information exists concerning the prevalence, geographic distribution, and genetic diversity of SFVs in wild-living monkeys and apes. Here, we report the first comprehensive survey of SFVcpz infection in free-ranging chimpanzees (Pan troglodytes) using newly developed, fecal-based assays. Chimpanzee fecal samples (n = 724) were collected at 25 field sites throughout equatorial Africa and tested for SFVcpz-specific antibodies (n = 706) or viral nucleic acids (n = 392). SFVcpz infection was documented at all field sites, with prevalence rates ranging from 44% to 100%. In two habituated communities, adult chimpanzees had significantly higher SFVcpz infection rates than infants and juveniles, indicating predominantly horizontal rather than vertical transmission routes. Some chimpanzees were co-infected with simian immunodeficiency virus (SIVcpz); however, there was no evidence that SFVcpz and SIVcpz were epidemiologically linked. SFVcpz nucleic acids were recovered from 177 fecal samples, all of which contained SFVcpz RNA and not DNA. Phylogenetic analysis of partial gag (616 bp), pol-RT (717 bp), and pol-IN (425 bp) sequences identified a diverse group of viruses, which could be subdivided into four distinct SFVcpz lineages according to their chimpanzee subspecies of origin. Within these lineages, there was evidence of frequent superinfection and viral recombination. One chimpanzee was infected by a foamy virus from a Cercopithecus monkey species, indicating cross-species transmission of SFVs in the wild. These data indicate that SFVcpz (i) is widely distributed among all chimpanzee subspecies; (ii) is shed in fecal samples as viral RNA; (iii) is transmitted predominantly by horizontal routes; (iv) is prone to superinfection and recombination; (v) has co-evolved with its natural host; and (vi) represents a sensitive marker of population structure that may be useful for chimpanzee taxonomy and conservation strategies.
识别野生灵长类动物中具有人畜共患病潜力的微生物病原体对人类健康可能至关重要,人类免疫缺陷病毒1型和2型(HIV-1和HIV-2)以及埃博拉病毒就是例证。猿猴泡沫病毒(SFV)是古老的逆转录病毒,可感染旧世界和新世界的猴子及猿类。尽管尚不明确这些病毒会引发疾病,但它们受到公共卫生领域的关注,因为它们有可能感染人类,从而更全面地表明人畜共患病暴露风险。令人惊讶的是,目前尚无关于野生猴子和猿类中SFV的流行情况、地理分布及遗传多样性的信息。在此,我们报告了首次使用新开发的基于粪便的检测方法,对自由放养黑猩猩(Pan troglodytes)中的猿猴泡沫病毒黑猩猩亚种(SFVcpz)感染进行的全面调查。在赤道非洲的25个野外地点采集了黑猩猩粪便样本(n = 724),并对其进行了SFVcpz特异性抗体检测(n = 706)或病毒核酸检测(n = 392)。在所有野外地点均记录到了SFVcpz感染,感染率在44%至100%之间。在两个习惯化群落中,成年黑猩猩的SFVcpz感染率显著高于婴儿和幼年黑猩猩,这表明主要传播途径是水平传播而非垂直传播。一些黑猩猩同时感染了猿猴免疫缺陷病毒(SIVcpz);然而,没有证据表明SFVcpz和SIVcpz在流行病学上存在关联。从177份粪便样本中检测到了SFVcpz核酸,所有样本均含有SFVcpz RNA而非DNA。对部分gag(616 bp)、pol-RT(717 bp)和pol-IN(425 bp)序列进行的系统发育分析确定了一组多样的病毒,根据其起源的黑猩猩亚种可将其细分为四个不同的SFVcpz谱系。在这些谱系中,存在频繁的双重感染和病毒重组的证据。一只黑猩猩感染了来自猕猴属物种的泡沫病毒,这表明野生环境中存在SFV的跨物种传播。这些数据表明,SFVcpz(i)在所有黑猩猩亚种中广泛分布;(ii)以病毒RNA的形式在粪便样本中排出;(iii)主要通过水平途径传播;(iv)易于发生双重感染和重组;(v)与其天然宿主共同进化;(vi)代表了一种可能对黑猩猩分类学和保护策略有用的种群结构敏感标记。